Contact your GP if you experience severe or worsening fatigue impairing daily activities, symptoms of hypoglycaemia (especially if taking insulin or sulphonylureas), signs of dehydration, severe abdominal pain, or fatigue accompanied by other concerning symptoms such as unexplained weight loss, fever, or mood changes
The clinical translation is further hampered by unclear pharmacokinetics and delivery hurdles, including poorly characterized in vivo metabolic fate, bioavailability, and optimal dosage windows, coupled with a lack of advanced formulation strategies for efficient and targeted delivery
Lighter individuals or those with slower metabolisms may find 1,2001,400 calories optimal, while larger or more active patients often succeed at 1,6001,800 calories
Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study
Tirzepatide is a dual agonist, meaning it activates two hormone pathways: glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1